2021 Revenues ($USD) : $17,979,000,000
2021 R&D spend : not available
2021 Number of Employees : not available
Fiscal Year End : 12/31/2020
Key People : Rainer Blair, president and CEO; Jennifer Honeycutt, EVP; Matt McGrew, EVP and CFO; Joakim Weidemanis, EVP; Brian Ellis, SVP and general counsel; Jose-Carlos Gutierrez-Ramos, SVP and chief scientific officer; William King, SVP, strategic development; Angela Lalor, SVP, human resources; Robert Lutz, SVP and chief accounting officer; Daniel Raskas, SVP, corporate development.

About the company: Washington, D.C.-based Danaher is a global science and technology innovator with nearly 70,000 employees and research and development, manufacturing, sales, distribution, service and administrative facilities in more than 60 countries. Founded in 1984, Danaher is comprised of more than 20 operating companies organized as three segments: Life Sciences, Diagnostics and Environmental and Applied Solutions. Its Big 100 ranking jumped to No. 5 from a previous No. 10 thanks to the company’s $20 billion purchase of GE’s BioPharma business in early 2020.  Life Sciences was established in 2005 with Danaher’s acquisition of Leica Microsystems, and now offers instruments and consumables used to study genes, proteins, metabolites and cells to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines. Established in 2004 with the acquisition of Radiometer, the Diagnostics segment offers analytical instruments, reagents, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. Then-EVP Rainer Blair was promoted into the corner office after Tom Joyce’s retirement in September 2020. –JH